INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 1 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $0 | -100.0% | 100 | -98.4% | 0.00% | – |
| Q4 2017 | $2,000 | -97.1% | 6,300 | -77.0% | 0.00% | -100.0% |
| Q3 2017 | $68,000 | -66.5% | 27,400 | -58.7% | 0.00% | -62.5% |
| Q2 2017 | $203,000 | +16.7% | 66,300 | -49.2% | 0.01% | 0.0% |
| Q1 2017 | $174,000 | +114.8% | 130,461 | +38.0% | 0.01% | +166.7% |
| Q4 2016 | $81,000 | -20.6% | 94,557 | +65.9% | 0.00% | -40.0% |
| Q3 2016 | $102,000 | -77.4% | 57,002 | -4.0% | 0.01% | -78.3% |
| Q2 2016 | $452,000 | -0.7% | 59,400 | -52.6% | 0.02% | -25.8% |
| Q1 2016 | $455,000 | +83.5% | 125,276 | +190.1% | 0.03% | +121.4% |
| Q4 2015 | $248,000 | – | 43,182 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 788,175 | $10,199,000 | 4.68% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,987,313 | $116,296,000 | 2.40% |
| Antipodean Advisors LLC | 305,294 | $3,951,000 | 2.39% |
| Freshford Capital Management, LLC | 475,984 | $6,159,000 | 1.81% |
| Folger Hill Asset Management LP | 1,597,945 | $20,677,000 | 1.61% |
| JW Asset Management, LLC | 150,638 | $1,949,000 | 1.55% |
| 12 West Capital Management LP | 623,791 | $8,072,000 | 1.30% |
| Orbimed Advisors | 4,688,240 | $60,666,000 | 0.63% |
| CYPRESS FUNDS LLC | 135,584 | $1,754,000 | 0.41% |
| Rock Springs Capital Management LP | 365,500 | $4,730,000 | 0.35% |